Search Media Coverage


To refine your search select a single option or a combination of options:

reset
 

Media Coverage

Displaying Media Coverage item(s) about Supreme Court & Appellate
1/2/3/4/5Next 98 results
 
  • April 19, 2021
     
    The American Lawyer
    Our runners-up this week are highlighted by a Latham team who landed a US$1.8 billion settlement for electric vehicle battery maker LG Energy Solution in a trade secrets showdown, a settlement that was praised by the White House.
     
    Share
    view
  • April 15, 2021
     
    Law360
    The Ninth Circuit refused to revive a shareholder suit claiming Emulex Corp. negligently omitted unsavory information about a US$606 million acquisition offer, but punted on the larger issue of whether private plaintiffs can bring such lawsuits at all.
     
    Share
    view
  • March 24, 2021
     
    Bloomberg Law
    Supreme Court and Appellate associate honored as one of five fresh faces making their mark in key cases before the US Supreme Court and federal circuit courts across the country.
     
    Share
    view
  • January 08, 2021
     
    Law360
    Steven Feldman brings a wide array of high-stakes litigation experience across industries to the firm’s battle-tested trial team.
     
    Share
    view
  • January 08, 2021
     
    Law360
    The Second Circuit affirmed Latham and the NAACP's win in a bench trial over a school district's effective block of Black and Latino voters' preferred candidates from the school board, supporting the finding that the district violated the Voting Rights Act.
     
    Share
    view
  • December 08, 2020
     
    Law360
    Supreme Court & Appellate partner Roman Martinez, counsel for the National Organization of Veteran’s Advocates, said that the ruling is "an enormous victory for our nation's veterans."
     
    Share
    view
  • December 02, 2020
     
    Law360
    Firm recognized for beating multiple big-ticket securities actions and helping pave the way for new law on forum selection provisions in initial public offering documents.
     
    Share
    view
  • November 23, 2020
     
    Law360
    The Federal Circuit affirmed a Delaware federal judge's ruling that Hospira's generic version of Par Pharmaceutical's epinephrine emergency allergy product Adrenalin infringes two valid patents covering the drug.
     
    Share
    view
 
1/2/3/4/5Next
 
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.